Hal P. Bogerd

8.8k total citations
78 papers, 7.3k citations indexed

About

Hal P. Bogerd is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Hal P. Bogerd has authored 78 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 27 papers in Virology and 22 papers in Immunology. Recurrent topics in Hal P. Bogerd's work include RNA Research and Splicing (33 papers), HIV Research and Treatment (27 papers) and RNA modifications and cancer (14 papers). Hal P. Bogerd is often cited by papers focused on RNA Research and Splicing (33 papers), HIV Research and Treatment (27 papers) and RNA modifications and cancer (14 papers). Hal P. Bogerd collaborates with scholars based in United States, Switzerland and Taiwan. Hal P. Bogerd's co-authors include Bryan R. Cullen, Heather L. Wiegand, Robert A. Fridell, Brian Doehle, Edward M. Kennedy, Paul D. Bieniasz, R. Edward Benson, Anand Kornepati, Steven J. Madore and Jian Hua and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Hal P. Bogerd

78 papers receiving 7.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hal P. Bogerd United States 47 4.8k 2.2k 1.8k 1.2k 1.1k 78 7.3k
Monsef Benkirane France 46 4.4k 0.9× 4.0k 1.9× 3.1k 1.8× 1.4k 1.2× 1.6k 1.5× 77 8.4k
D Baltimore United States 16 3.3k 0.7× 1.2k 0.6× 2.7k 1.6× 537 0.5× 721 0.7× 17 6.6k
Shu‐Yun Le United States 30 3.4k 0.7× 1.1k 0.5× 620 0.4× 384 0.3× 747 0.7× 63 4.7k
Abraham L. Brass United States 33 2.7k 0.6× 1.9k 0.9× 3.2k 1.8× 2.0k 1.7× 2.3k 2.1× 55 7.3k
Amos Panet Israel 42 2.9k 0.6× 936 0.4× 1.3k 0.8× 1.4k 1.2× 927 0.9× 175 5.7k
Richard Bénarous France 43 3.7k 0.8× 3.3k 1.5× 1.5k 0.8× 1.2k 1.0× 1.8k 1.6× 88 6.8k
Anne Gatignol Canada 41 3.9k 0.8× 1.5k 0.7× 1.1k 0.6× 455 0.4× 603 0.6× 80 5.1k
Richard W. Moyer United States 37 2.5k 0.5× 1.6k 0.8× 1.1k 0.6× 1.7k 1.5× 262 0.2× 128 5.5k
Hung Fan United States 35 1.9k 0.4× 785 0.4× 853 0.5× 705 0.6× 321 0.3× 103 4.4k
P J Barr United States 39 3.0k 0.6× 849 0.4× 1.3k 0.7× 1.8k 1.5× 771 0.7× 66 7.0k

Countries citing papers authored by Hal P. Bogerd

Since Specialization
Citations

This map shows the geographic impact of Hal P. Bogerd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hal P. Bogerd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hal P. Bogerd more than expected).

Fields of papers citing papers by Hal P. Bogerd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hal P. Bogerd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hal P. Bogerd. The network helps show where Hal P. Bogerd may publish in the future.

Co-authorship network of co-authors of Hal P. Bogerd

This figure shows the co-authorship network connecting the top 25 collaborators of Hal P. Bogerd. A scholar is included among the top collaborators of Hal P. Bogerd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hal P. Bogerd. Hal P. Bogerd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irwan, Ishak D., Hal P. Bogerd, & Bryan R. Cullen. (2022). Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency. Nature Microbiology. 7(12). 2101–2113. 21 indexed citations
2.
Tsai, Kevin, et al.. (2021). Mapping of pseudouridine residues on cellular and viral transcripts using a novel antibody-based technique. RNA. 27(11). 1400–1411. 23 indexed citations
3.
Tsai, Kevin, Hal P. Bogerd, Edward M. Kennedy, et al.. (2021). Epitranscriptomic addition of m 6 A regulates HIV-1 RNA stability and alternative splicing. Genes & Development. 35(13-14). 992–1004. 50 indexed citations
4.
Irwan, Ishak D., et al.. (2020). Reversal of Epigenetic Silencing Allows Robust HIV-1 Replication in the Absence of Integrase Function. mBio. 11(3). 19 indexed citations
5.
Courtney, David, Hal P. Bogerd, Brittany A. Law, et al.. (2019). Extensive Epitranscriptomic Methylation of A and C Residues on Murine Leukemia Virus Transcripts Enhances Viral Gene Expression. mBio. 10(3). 53 indexed citations
6.
Courtney, David, Edward M. Kennedy, Rebekah E. Dumm, et al.. (2017). Epitranscriptomic Enhancement of Influenza A Virus Gene Expression and Replication. Cell Host & Microbe. 22(3). 377–386.e5. 175 indexed citations
7.
Kennedy, Edward M., Hal P. Bogerd, Anand Kornepati, et al.. (2016). Posttranscriptional m6A Editing of HIV-1 mRNAs Enhances Viral Gene Expression. Cell Host & Microbe. 19(5). 675–685. 307 indexed citations
8.
Kornepati, Anand, et al.. (2015). Expression of CRISPR/Cas single guide RNAs using small tRNA promoters. RNA. 21(9). 1683–1689. 48 indexed citations
9.
Kennedy, Edward M., Leda Bassit, H. Mueller, et al.. (2014). Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease. Virology. 476. 196–205. 194 indexed citations
10.
Bogerd, Hal P., Fengwen Zhang, Paul D. Bieniasz, & Bryan R. Cullen. (2010). Human APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity. Virology. 410(1). 234–239. 20 indexed citations
11.
Bogerd, Hal P., et al.. (2010). A Mammalian Herpesvirus Uses Noncanonical Expression and Processing Mechanisms to Generate Viral MicroRNAs. Molecular Cell. 37(1). 135–142. 161 indexed citations
12.
Bogerd, Hal P. & Bryan R. Cullen. (2008). Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation. RNA. 14(6). 1228–1236. 59 indexed citations
13.
Bogerd, Hal P.. (2006). APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Research. 34(1). 89–95. 226 indexed citations
14.
Schäfer, Alexandra, Hal P. Bogerd, & Bryan R. Cullen. (2004). Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Virology. 328(2). 163–168. 191 indexed citations
15.
Wiegand, Heather L., Brian Doehle, Hal P. Bogerd, & Bryan R. Cullen. (2004). A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins. The EMBO Journal. 23(12). 2451–2458. 396 indexed citations
16.
Bogerd, Hal P., et al.. (2000). The human endogenous retrovirus K Rev response element coincides with a predicted RNA folding region. RNA. 6(11). 1551–1564. 22 indexed citations
18.
Truant, Ray, Robert A. Fridell, R. Edward Benson, Hal P. Bogerd, & Bryan R. Cullen. (1998). Identification and Functional Characterization of a Novel Nuclear Localization Signal Present in the Yeast Nab2 Poly(A) + RNA Binding Protein. Molecular and Cellular Biology. 18(3). 1449–1458. 60 indexed citations
19.
Fridell, Robert A., R. Edward Benson, Jian Hua, Hal P. Bogerd, & Bryan R. Cullen. (1996). A nuclear role for the Fragile X mental retardation protein.. The EMBO Journal. 15(19). 5408–5414. 110 indexed citations
20.
Cianciolo, George J., Hal P. Bogerd, & Ralph Snyderman. (1988). Human retrovirus-related synthetic peptides inhibit T lymphocyte proliferation. Immunology Letters. 19(1). 7–13. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026